Over the years, many hands have been wrung over clinical trial recruitment – low participation ... But in a world of patient engagement and ubiquitous technology, part of the answer seems ...

Patient recruitment remains a significant challenge for biopharma companies, often leading to delays and increased costs in clinical trials. Traditional recruitment methods can be time-consuming ...

Who is managing patient recruitment strategies for the trial? The Australian Clinical Trial Network (ACTioN) is engaged to implement patient recruitment and retention strategies for the trial.

Conducting clinical trials is undoubtedly complex, but the rewards are immeasurable for advancing healthcare and improving ...

One major way AI is set to revolutionise clinical trials is by automating patient recruitment, which is typically the most ...

With chemotherapy currently the main form of treatment, HG-CT-1 is based on a potentially more benign and effective CAR-T therapy, which uses and modifies a patient's own immune cells to recognize and ...

Dimerix recruits Part 2 cohort of patients for ACTION3 global phase III trial Interim analysis data collection currently ...

Patient screening underway; first patient expected to be randomized into the study in January A leading clinical trial site management organization (SMO), Australian Clinical Trial Network (ACTioN), ...

An announcement from Psyence Biomedical ( (PBM) ) is now available.